Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Fourth Annual Celebrate Spring Boston Raises $50,000 for Parkinson’s Disease Foundation

Boston Area Women Inspire Fellow Young Professionals to End Parkinson’s

Young professionals in Boston, MA, led by Rehana Ashraf, Kate Evans and Anne Greene raised $50,000 for Parkinson’s research at the fourth annual Celebrate Spring Boston at The Liberty Hotel on April 29. They welcomed 180 guests, including New England Patriots alumni, to the event to benefit the Parkinson’s Disease Foundation (PDF).

Measured by net proceeds, this year's Celebrate Spring Boston was most successful yet, bringing the amount raised over four years for PDF research programs to $180,000.  Guests, including former New England Patriots players Harold Shaw, Jon Williams and Garin Veris, enjoyed an evening of cocktails, hors d’oeuvres, music, dancing and a silent auction.  The event Co-chairs say their goals are to advance research and motivate their generation to join PDF in ending the disease.

“Kate, Anne and I are driven to help end Parkinson’s in honor of our loved ones, including my late father. We know that our generation is an important part of the team that will move the Parkinson’s Disease Foundation closer to a cure. We are grateful for the tremendous response from young professionals in Boston who help make this event a success by advancing Parkinson’s research,” says Ms. Ashraf.

Event proceeds benefit the work of PDF Research Fellow, Nan Li, Ph.D., of the Massachusetts Institute of Technology.  Dr. Li, who is using cutting-edge imaging technology to study Parkinson’s, is supported through a PDF fellowship program designed to keep talented young scientists in the field. 

About Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects nearly one million people in the US.  Although promising research is being conducted, there is currently no cure for Parkinson’s.

Tuesday, May 3, 2016
In Memory of Robert Traurig
Wednesday, July 18, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member Robert (Bob) Traurig. From 2004 to 2015, he was a member of the Foundation’s board of directors. Bob is survived by his wife Jacqueline, his daughters Madeline Sackel and Wendy Traurig.

New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.